Mono‐ and bis‐edaravone adducts formed in the presence of vanillin in an aqueous solution-Reference-Cited by-同舟云学术

Mono‐ and bis‐edaravone adducts formed in the presence of vanillin in an aqueous solution

Published:2022-04-26 Issue:7 Volume:5 Page:285-295
ISSN:2573-1815
Container-title:SEPARATION SCIENCE PLUS
language:en
Short-container-title:Separation Science Plus

Author:

Regnault Romain¹,Kouach Mostafa¹,Goossens Laurence¹,Thuru Xavier²,Bailly Christian³^ORCID,Goossens Jean‐François¹

Affiliation:

1. CHU Lille, ULR 7365 ‐ GRITA ‐ Groupe de Recherche sur les formes Injectables et les Technologies Associées Univ. Lille Lille France

2. CHU Lille, CNRS, Inserm, UMR9020 – UMR1277 – Canther – Cancer Heterogeneity, Plasticity and Resistance to Therapies Univ. Lille Lille France

3. Oncowitan Scientific Consulting Office Lille France

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sscp.202200031

Reference34 articles.

1. Edaravone for the treatment of amyotrophic lateral sclerosis

2. Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis

3. The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis

4. Post‐marketing experience of edaravone in amyotrophic lateral sclerosis: a clinical perspective and comparison with the clinical trials of the drug;Ortiz JF;. Cureus.,2020

5. Therapeutic news in ALS

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties;Molecules;2023-04-15

2. Antioxidant Properties and Aldehyde Reactivity of PD-L1 Targeted Aryl-Pyrazolone Anticancer Agents;Molecules;2022-05-21